Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
2.775
-0.135 (-4.64%)
Mar 31, 2025, 1:41 PM EDT - Market open
Savara Market Cap
Savara has a market cap or net worth of $584.07 million as of March 31, 2025. Its market cap has decreased by -13.54% in one year.
Market Cap
584.07M
Enterprise Value
442.55M
1-Year Change
-13.54%
Ranking
Category
Stock Price
$2.78
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $584.07M, an increase of 340.14%. That is a compound annual growth rate of 20.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 502.40M | -4.65% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |